Stocks
Atara Biotherapeutics (ATRA) EV/EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EV/EBITDA | ? | -3.42 | 0.77 | -0.02 | -1.33 | 7.02 | -25.4 | |
| Changes by years, y/y, % | +7% | -122% | -103% | +5 670% | -627% | |||
Atara Biotherapeutics. EV/EBITDA
Atara Biotherapeutics. EV/EBITDA, changes, %
Atara Biotherapeutics (ATRA) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -18.3 | 6.25 | 7.85 | 7.02 | -12.5 | -25.4 | |
| Changes by years, y/y, % | +40 758% | -6 239% | -1 748% | -470% | -32% | |||
| Changes by quarters, q/q, % | +865% | -134% | +25% | -11% | -278% | |||
